Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32997121.
- Also identified by DOI 10.1001/jamanetworkopen.2020.19801 and PMC identifier 7527872.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines the characteristics and outcomes of patients for whom transcatheter aortic valve replacement (TAVR) was deferred because of the coronavirus disease 2019 (COVID-19) pandemic.
Medical subject headings
- Aortic Valve Stenosis
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Time-to-Treatment
- Transcatheter Aortic Valve Replacement